3
Announcements
Trials
Browse
Landscape
Status
Recruiting
3
Unknown
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Myelodysplastic Syndromes
100
Leukemia, Myeloid, Acute
79
Precursor Cell Lymphoblastic Leukemia-Lymphoma
40
Myeloproliferative Disorders
40
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
37
Leukemia, Myelomonocytic, Chronic
32
Primary Myelofibrosis
30
Lymphoma, Non-Hodgkin
30
Polycythemia Vera
19
Lymphoma
15
Leukemia
15
Hematologic Neoplasms
15
Leukemia, Biphenotypic, Acute
14
Thrombocythemia, Essential
13
Multiple Myeloma
11
Hodgkin Disease
11
Histiocytosis, Langerhans-Cell
11
Neoplasms
10
Leukemia, Myeloid, Chronic-Phase
10
Leukemia, Lymphocytic, Chronic, B-Cell
10
Rhabdoid Tumor
9
Neuroblastoma
9
Medulloblastoma
9
Glioma
9
Ependymoma
9
Anemia, Refractory, with Excess of Blasts
9
Wilms Tumor
8
Sarcoma
8
Rhabdomyosarcoma
8
Osteosarcoma
8
Interventions
ruxolitinib
1
Stem Cell Transplantation
1
Hydroxyurea
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Bone Marrow Neoplasms
×
Myeloid
×
Clear all
NCT04217356
2026-01-26
ALLO-BAT
University Health Network, Toronto
Active not recruiting
90 enrolled